Synopsis
0
EU WC
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - INJECTABLE;INJECTION - 0.5MG/5ML (0....DOSAGE - INJECTABLE;INJECTION - 0.5MG/5ML (0.1MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 20073
DOSAGE - INJECTABLE;INJECTION - 1MG/10ML (0.1...DOSAGE - INJECTABLE;INJECTION - 1MG/10ML (0.1MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 20073
Related Excipient Companies
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
65
PharmaCompass offers a list of Flumazenil API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Flumazenil manufacturer or Flumazenil supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Flumazenil manufacturer or Flumazenil supplier.
PharmaCompass also assists you with knowing the Flumazenil API Price utilized in the formulation of products. Flumazenil API Price is not always fixed or binding as the Flumazenil Price is obtained through a variety of data sources. The Flumazenil Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A DSSTox_CID_3064 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of DSSTox_CID_3064, including repackagers and relabelers. The FDA regulates DSSTox_CID_3064 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. DSSTox_CID_3064 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of DSSTox_CID_3064 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A DSSTox_CID_3064 supplier is an individual or a company that provides DSSTox_CID_3064 active pharmaceutical ingredient (API) or DSSTox_CID_3064 finished formulations upon request. The DSSTox_CID_3064 suppliers may include DSSTox_CID_3064 API manufacturers, exporters, distributors and traders.
click here to find a list of DSSTox_CID_3064 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A DSSTox_CID_3064 DMF (Drug Master File) is a document detailing the whole manufacturing process of DSSTox_CID_3064 active pharmaceutical ingredient (API) in detail. Different forms of DSSTox_CID_3064 DMFs exist exist since differing nations have different regulations, such as DSSTox_CID_3064 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A DSSTox_CID_3064 DMF submitted to regulatory agencies in the US is known as a USDMF. DSSTox_CID_3064 USDMF includes data on DSSTox_CID_3064's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The DSSTox_CID_3064 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of DSSTox_CID_3064 suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The DSSTox_CID_3064 Drug Master File in Japan (DSSTox_CID_3064 JDMF) empowers DSSTox_CID_3064 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the DSSTox_CID_3064 JDMF during the approval evaluation for pharmaceutical products. At the time of DSSTox_CID_3064 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of DSSTox_CID_3064 suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a DSSTox_CID_3064 Drug Master File in Korea (DSSTox_CID_3064 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of DSSTox_CID_3064. The MFDS reviews the DSSTox_CID_3064 KDMF as part of the drug registration process and uses the information provided in the DSSTox_CID_3064 KDMF to evaluate the safety and efficacy of the drug.
After submitting a DSSTox_CID_3064 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their DSSTox_CID_3064 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of DSSTox_CID_3064 suppliers with KDMF on PharmaCompass.
A DSSTox_CID_3064 CEP of the European Pharmacopoeia monograph is often referred to as a DSSTox_CID_3064 Certificate of Suitability (COS). The purpose of a DSSTox_CID_3064 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of DSSTox_CID_3064 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of DSSTox_CID_3064 to their clients by showing that a DSSTox_CID_3064 CEP has been issued for it. The manufacturer submits a DSSTox_CID_3064 CEP (COS) as part of the market authorization procedure, and it takes on the role of a DSSTox_CID_3064 CEP holder for the record. Additionally, the data presented in the DSSTox_CID_3064 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the DSSTox_CID_3064 DMF.
A DSSTox_CID_3064 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. DSSTox_CID_3064 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of DSSTox_CID_3064 suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing DSSTox_CID_3064 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for DSSTox_CID_3064 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture DSSTox_CID_3064 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain DSSTox_CID_3064 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a DSSTox_CID_3064 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of DSSTox_CID_3064 suppliers with NDC on PharmaCompass.
DSSTox_CID_3064 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of DSSTox_CID_3064 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right DSSTox_CID_3064 GMP manufacturer or DSSTox_CID_3064 GMP API supplier for your needs.
A DSSTox_CID_3064 CoA (Certificate of Analysis) is a formal document that attests to DSSTox_CID_3064's compliance with DSSTox_CID_3064 specifications and serves as a tool for batch-level quality control.
DSSTox_CID_3064 CoA mostly includes findings from lab analyses of a specific batch. For each DSSTox_CID_3064 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
DSSTox_CID_3064 may be tested according to a variety of international standards, such as European Pharmacopoeia (DSSTox_CID_3064 EP), DSSTox_CID_3064 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (DSSTox_CID_3064 USP).
